ARTL
NASDAQ · Pharmaceuticals
Artelo Biosciences Inc
$0.75
0.00 (-0.19%)
Open$0.78
Previous Close$0.75
Day High$0.78
Day Low$0.74
52W High$31.65
52W Low$0.71
Volume—
Avg Volume149.4K
Market Cap2.58M
P/E Ratio—
EPS$-38.91
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+1,990.5% upside
Current
$0.75
$0.75
Target
$15.70
$15.70
$11.87
$15.70 avg
$22.80
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 653.2K | 640.4K | 651.1K |
| Net Income | 176.4K | 175.3K | 172.4K |
| Profit Margin | 27.0% | 27.4% | 26.5% |
| EBITDA | 261.8K | 256.2K | 270.8K |
| Free Cash Flow | 66.8K | 83.8K | 75.0K |
| Rev Growth | -7.3% | -5.3% | +22.2% |
| Debt/Equity | 0.34 | 0.30 | 0.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |